| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia
|
Pavlů, Jiří
|
|
2012
|
8 |
1 |
p. 43-51
|
artikel
|
| 2 |
CARs in Chronic Lymphocytic Leukemia – Ready to Drive
|
Hosing, Chitra
|
|
2012
|
8 |
1 |
p. 60-70
|
artikel
|
| 3 |
GS-1101: A Delta-Specific PI3K Inhibitor in Chronic Lymphocytic Leukemia
|
Macias-Perez, Ines M.
|
|
2012
|
8 |
1 |
p. 22-27
|
artikel
|
| 4 |
Ibrutinib (PCI-32765), the First BTK (Bruton’s Tyrosine Kinase) Inhibitor in Clinical Trials
|
Brown, Jennifer R.
|
|
2013
|
8 |
1 |
p. 1-6
|
artikel
|
| 5 |
Lenalidomide Alone and in Combination for Chronic Lymphocytic Leukemia
|
Chen, Christine I.
|
|
2012
|
8 |
1 |
p. 7-13
|
artikel
|
| 6 |
Management of the New Patient with CML in Chronic Phase
|
Marin, David
|
|
2013
|
8 |
1 |
p. 37-42
|
artikel
|
| 7 |
Monoclonal B Cell Lymphocytosis—What Does It Really Mean?
|
Rawstron, Andy C.
|
|
2013
|
8 |
1 |
p. 52-59
|
artikel
|
| 8 |
Role of Epigenetics in Chronic Myeloid Leukemia
|
Machova Polakova, Katerina
|
|
2013
|
8 |
1 |
p. 28-36
|
artikel
|
| 9 |
Signal Transduction in the Chronic Leukemias: Implications for Targeted Therapies
|
Ahmed, Wesam
|
|
2013
|
8 |
1 |
p. 71-80
|
artikel
|
| 10 |
Targeting Chronic Myeloid Leukemia Stem Cells
|
Kinstrie, Ross
|
|
2012
|
8 |
1 |
p. 14-21
|
artikel
|
| 11 |
What Do We Do with Chronic Lymphocytic Leukemia with 17p Deletion?
|
Sellner, L.
|
|
2012
|
8 |
1 |
p. 81-90
|
artikel
|
Tijdschrift beschrijving